Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy.

Related Articles

Shadow study: randomized comparison of clinic with video follow-up in glioma undergoing adjuvant temozolomide therapy.

CNS Oncol. 2018 Apr 30;:

Authors: Patil VM, Pande N, Chandrasekharan A, M C, Tonse R, Krishnatry R, Goda JS, Dsouza H, Vallathol DH, Chakraborty S, Gupta T, Jalali R

Abstract
AIM: This study was designed with a primary objective to study the rate of agreement in treatment plan and decisions between video follow-up (VF) and conventional clinic follow-up (CF).
PATIENTS & METHODS: Adult patients with intermediate- to high-grade glioma on adjuvant temozolomide (TMZ) with facilities for live video call were invited to participate in the study.
RESULTS: The concurrence in decision of administering TMZ between VF and CF was 100% (p < 0.00). The median cost incurred in VF was US$58.15 while that incurred in CF was US$131.23 (p < 0.00).
CONCLUSION: VF can substitute CF during adjuvant TMZ administration (CTRI/2017/01/007626).

PMID: 29708400 [PubMed - as supplied by publisher]

https://ift.tt/2w3vazY